UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000020891 |
|---|---|
| Receipt number | R000024102 |
| Scientific Title | Phase II study of VAC1.2(vincristine, actinomycin-D, cyclophosphamide) followed by VA for patients with newly diagnosed low-risk subset A rhabdomyosarcoma |
| Date of disclosure of the study information | 2016/03/01 |
| Last modified on | 2020/08/08 11:19:30 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/02/04 23:02:01 | ||
| 2 | Update | 2016/05/27 08:42:43 | Name of primary person or sponsor Organization Category of Funding Organization Research ethics review |
|
| 3 | Update | 2016/05/27 08:44:17 | Anticipated trial start date |
|
| 4 | Update | 2016/05/27 08:45:26 | Recruitment status |
|
| 5 | Update | 2018/08/08 22:16:41 | Recruitment status |
|
| 6 | Update | 2020/08/08 11:19:30 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Division name Zip code Last name of contact person Last name of contact person Division name Zip code Division name Organization Organization Address Address Tel |
